Javascript must be enabled to continue!
The epidemiology, molecular pathogenesis, diagnosis, and treatment of maturity-onset diabetes of the young (MODY)
View through CrossRef
AbstractBackgroundThe most common type of monogenic diabetes is maturity-onset diabetes of the young (MODY), a clinically and genetically heterogeneous group of endocrine disorders that affect 1–5% of all patients with diabetes mellitus. MODY is characterized by autosomal dominant inheritance but de novo mutations have been reported. Clinical features of MODY include young-onset hyperglycemia, evidence of residual pancreatic function, and lack of beta cell autoimmunity or insulin resistance. Glucose-lowering medications are the main treatment options for MODY. The growing recognition of the clinical and public health significance of MODY by clinicians, researchers, and governments may lead to improved screening and diagnostic practices. Consequently, this review article aims to discuss the epidemiology, pathogenesis, diagnosis, and treatment of MODY based on relevant literature published from 1975 to 2020.Main bodyThe estimated prevalence of MODY from European cohorts is 1 per 10,000 in adults and 1 per 23,000 in children. Since little is known about the prevalence of MODY in African, Asian, South American, and Middle Eastern populations, further research in non-European cohorts is needed to help elucidate MODY’s exact prevalence. Currently, 14 distinct subtypes of MODY can be diagnosed through clinical assessment and genetic analysis. Various genetic mutations and disease mechanisms contribute to the pathogenesis of MODY. Management of MODY is subtype-specific and includes diet, oral antidiabetic drugs, or insulin.ConclusionsIncidence and prevalence estimates for MODY are derived from epidemiologic studies of young people with diabetes who live in Europe, Australia, and North America. Mechanisms involved in the pathogenesis of MODY include defective transcriptional regulation, abnormal metabolic enzymes, protein misfolding, dysfunctional ion channels, or impaired signal transduction. Clinicians should understand the epidemiology and pathogenesis of MODY because such knowledge is crucial for accurate diagnosis, individualized patient management, and screening of family members.
Springer Science and Business Media LLC
Title: The epidemiology, molecular pathogenesis, diagnosis, and treatment of maturity-onset diabetes of the young (MODY)
Description:
AbstractBackgroundThe most common type of monogenic diabetes is maturity-onset diabetes of the young (MODY), a clinically and genetically heterogeneous group of endocrine disorders that affect 1–5% of all patients with diabetes mellitus.
MODY is characterized by autosomal dominant inheritance but de novo mutations have been reported.
Clinical features of MODY include young-onset hyperglycemia, evidence of residual pancreatic function, and lack of beta cell autoimmunity or insulin resistance.
Glucose-lowering medications are the main treatment options for MODY.
The growing recognition of the clinical and public health significance of MODY by clinicians, researchers, and governments may lead to improved screening and diagnostic practices.
Consequently, this review article aims to discuss the epidemiology, pathogenesis, diagnosis, and treatment of MODY based on relevant literature published from 1975 to 2020.
Main bodyThe estimated prevalence of MODY from European cohorts is 1 per 10,000 in adults and 1 per 23,000 in children.
Since little is known about the prevalence of MODY in African, Asian, South American, and Middle Eastern populations, further research in non-European cohorts is needed to help elucidate MODY’s exact prevalence.
Currently, 14 distinct subtypes of MODY can be diagnosed through clinical assessment and genetic analysis.
Various genetic mutations and disease mechanisms contribute to the pathogenesis of MODY.
Management of MODY is subtype-specific and includes diet, oral antidiabetic drugs, or insulin.
ConclusionsIncidence and prevalence estimates for MODY are derived from epidemiologic studies of young people with diabetes who live in Europe, Australia, and North America.
Mechanisms involved in the pathogenesis of MODY include defective transcriptional regulation, abnormal metabolic enzymes, protein misfolding, dysfunctional ion channels, or impaired signal transduction.
Clinicians should understand the epidemiology and pathogenesis of MODY because such knowledge is crucial for accurate diagnosis, individualized patient management, and screening of family members.
Related Results
Maturity Onset Diabetes of the Young (MODY) : Diagnosa dan Tatalaksana
Maturity Onset Diabetes of the Young (MODY) : Diagnosa dan Tatalaksana
Maturity Onset Diabetes of the Young (MODY), merupakan salah satu bentuk dari defek sel beta pankreas akibat mutasi genetik. Hingga saat ini terdapat lebih dari 10 mutasi fenotip g...
Institutional Quality Matter and Vietnamese Corporate Debt Maturity
Institutional Quality Matter and Vietnamese Corporate Debt Maturity
This article studies whether firm-level and country-level factors affect to the corporation's debt maturity in case of Vietnam or not. The paper adopts the balance panel data of 26...
Maturity-onset diabetes of the young: difficult differential diagnosis
Maturity-onset diabetes of the young: difficult differential diagnosis
Maturity-onset diabetes of the young (MODY) is a monogenic variant of diabetes characterized by the primary dysfunctions of pancreatic β-cells. MODY accounts for 1...
Can complement factors 5 and 8 and transthyretin be used as biomarkers for MODY 1 (HNF4A‐MODY) and MODY 3 (HNF1A‐MODY)?
Can complement factors 5 and 8 and transthyretin be used as biomarkers for MODY 1 (HNF4A‐MODY) and MODY 3 (HNF1A‐MODY)?
AbstractAims Genetic testing is needed for the formal diagnosis of maturity‐onset diabetes of the young (MODY), but this is not widely available. If any MODY biomarkers were known...
Type 1 diabetes in young women : aspects on person-centered care and BMI in risk assessment
Type 1 diabetes in young women : aspects on person-centered care and BMI in risk assessment
<p dir="ltr"><b>Background and aims</b></p><p dir="ltr">Young women with type 1 diabetes (T1D) have higher relative risks of vascular complications an...
Type 1 diabetes in young women : aspects on person-centered care and BMI in risk assessment
Type 1 diabetes in young women : aspects on person-centered care and BMI in risk assessment
<p dir="ltr"><b>Background and aims</b></p><p dir="ltr">Young women with type 1 diabetes (T1D) have higher relative risks of vascular complications an...
Meglitinide Analogues in Adolescent Patients With HNF1A-MODY (MODY 3)
Meglitinide Analogues in Adolescent Patients With HNF1A-MODY (MODY 3)
For pediatric patients with hepatocyte nuclear factor-1A (HNF1A)–maturity-onset diabetes of the young (MODY 3), treatment with sulfonylureas is recommended. In adults with HNF1A-MO...
Clinical and Genetic Features of Maturity-onset Diabetes of the Young in Pediatric Patients: a 12-year Monocentric Experience
Clinical and Genetic Features of Maturity-onset Diabetes of the Young in Pediatric Patients: a 12-year Monocentric Experience
Abstract
Background. A retrospective observational study was conducted to assess the prevalence of maturity onset diabetes of the young (MODY) in a large paediatric populat...

